According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...
(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Peach buds may be far less dormant than scientists once believed. This study shows that vegetative buds in peach do not simply shut down during winter. Instead, they remain developmentally active, ...
Dr Aaron Wenger reveals how improvements in long-read sequencing technology is enabling the elucidation of complex disease ...
Qlucore, listed on Nasdaq First North, announces the launch of a new Qlucore Insights test (Research Use Only) specifically developed for Acute Myeloid Leukemia (AML). The software-based test delivers ...
Caris POA members advance precision medicine through collaborative research aimed at improving clinical outcomes for cancer ...
Explore Caris AI oncology diagnostics: molecular profiling, AI clinico-genomic data, 2025 growth, pipeline, and valuation after IPO pullback—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results